IFN-γ or IFN-α Ameliorates chronic proliferative dermatitis by inducing expression of linear ubiquitin chain assembly complex

Journal of Immunology

Volumn 192, Issue 8, 2014, Pages 3793-3804

  Tamiya, Hironari ^a,b   Terao, Mika ^b   Takiuchi, Tsuyoshi ^a,b   Nakahara, Masaki ^a   Sasaki, Yoshiteru ^a   Katayama, Ichiro ^b   Yoshikawa, Hideki ^b   Iwai, Kazuhiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE; CHRONIC DISEASE; DERMATITIS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INTERFERON-ALPHA; INTERFERON-GAMMA; MACROPHAGES; MAST CELLS; MICE; MULTIPROTEIN COMPLEXES; NEUTROPHILS; NF-KAPPA B; SKIN; UBIQUITIN-PROTEIN LIGASES;

EID: 84898622354     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302308     Document Type: Article

References (55)

1. Tokunaga, F., S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako, K. Kamei, T. Nakagawa, M. Kato, S. Murata, S. Yamaoka, et al. 2009. Involvement of linear polyubiquitylation of NEMO in NF-κB activation. Nat. Cell Biol. 11: 123-132.
2. Kirisako, T., K. Kamei, S. Murata, M. Kato, H. Fukumoto, M. Kanie, S. Sano, F. Tokunaga, K. Tanaka, and K. Iwai. 2006. A ubiquitin ligase complex assembles linear polyubiquitin chains. EMBO J. 25: 4877-4887.
3. Karin, M. 2006. Nuclear factor-kB in cancer development and progression. Nature 441: 431-436.
4. Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-κB. Genes Dev. 18: 2195-2224.
5. Hayden, M. S., and S. Ghosh. 2008. Shared principles in NF-κB signaling. Cell 132: 344-362.
6. Miyazawa, K., A. Mori, K. Yamamoto, and H. Okudaira. 1998. Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-κB and CBF1. Am. J. Pathol. 152: 793-803.
7. Criswell, L. A. 2010. Gene discovery in rheumatoid arthritis highlights the CD40/NF-κB signaling pathway in disease pathogenesis. Immunol. Rev. 233: 55-61.
8. Brambilla, R., T. Persaud, X. Hu, S. Karmally, V. I. Shestopalov, G. Dvoriantchikova, D. Ivanov, L. Nathanson, S. R. Barnum, and J. R. Bethea. 2009. Transgenic inhibition of astroglial NF-κB improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J. Immunol. 182: 2628-2640.
9. Hayden, M. S., and S. Ghosh. 2011. NF-κB in immunobiology. Cell Res. 21: 223-244.
10. Oeckinghaus, A., and S. Ghosh. 2009. The NF-κB family of transcription factors and its regulation. Cold Spring Harb. Perspect. Biol. 1: a000034.
11. Rothwarf, D. M., E. Zandi, G. Natoli, and M. Karin. 1998. IKK-γ is an essential regulatory subunit of the IkB kinase complex. Nature 395: 297-300.
12. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-[k]B activity. Annu. Rev. Immunol. 18: 621-663.
13. Yamaoka, S., G. Courtois, C. Bessia, S. T. Whiteside, R.Weil, F. Agou, H. E. Kirk, R. J. Kay, and A. Israël. 1998. Complementation cloning of NEMO, a component of the IkB kinase complex essential for NF-κB activation. Cell 93: 1231-1240.
14. Gijbels, M. J., C. Zurcher, G. Kraal, G. R. Elliott, H. HogenEsch, G. Schijff, H. F. Savelkoul, and P. L. Bruijnzeel. 1996. Pathogenesis of skin lesions in mice with chronic proliferative dermatitis (cpdm/cpdm). Am. J. Pathol. 148: 941-950.
15. HogenEsch, H., M. J. Gijbels, E. Offerman, J. van Hooft, D. W. van Bekkum, and C. Zurcher. 1993. A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am. J. Pathol. 143: 972-982.
16. Gerlach, B., S. M. Cordier, A. C. Schmukle, C. H. Emmerich, E. Rieser, T. L. Haas, A. I. Webb, J. A. Rickard, H. Anderton, W. W. Wong, et al. 2011. Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471: 591-596.
17. Ikeda, F., Y. L. Deribe, S. S. Skånland, B. Stieglitz, C. Grabbe, M. Franz-Wachtel, S. J. van Wijk, P. Goswami, V. Nagy, J. Terzic, et al. 2011. SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis. Nature 471: 637-641.
18. Takeshita, S., K. Kaji, and A. Kudo. 2000. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J. Bone Miner. Res. 15: 1477-1488.
19. Tokunaga, F., T. Nakagawa, M. Nakahara, Y. Saeki, M. Taniguchi, S. Sakata, K. Tanaka, H. Nakano, and K. Iwai. 2011. SHARPIN is a component of the NFkB-activating linear ubiquitin chain assembly complex. Nature 471: 633-636.
20. Matsuda, H., N. Watanabe, G. P. Geba, J. Sperl, M. Tsudzuki, J. Hiroi, M. Matsumoto, H. Ushio, S. Saito, P. W. Askenase, and C. Ra. 1997. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/ Nga mice. Int. Immunol. 9: 461-466.
21. Kohda, K., T. Ishibashi, N. Shimbara, K. Tanaka, Y. Matsuda, and M. Kasahara. 1998. Characterization of the mouse PA28 activator complex gene family: complete organizations of the three member genes and a physical map of the approximately 150-kb region containing the a-and b-subunit genes. J. Immunol. 160: 4923-4935.
22. Tanaka, K., and M. Kasahara. 1998. The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-g-inducible proteasome activator PA28. Immunol. Rev. 163: 161-176.
23. Hu, J., Q. Meng, S. K. Roy, A. Raha, J. Hu, J. Zhang, K. Hashimoto, and D. V. Kalvakolanu. 2002. A novel transactivating factor that regulates interferong-dependent gene expression. J. Biol. Chem. 277: 30253-30263.
24. Weihua, X., V. Kolla, and D. V. Kalvakolanu. 1997. Interferon g-induced transcription of the murine ISGF3g (p48) gene is mediated by novel factors. Proc. Natl. Acad. Sci. USA 94: 103-108.
25. Schroder, K., P. J. Hertzog, T. Ravasi, and D. A. Hume. 2004. Interferon-g: an overview of signals, mechanisms and functions. J. Leukoc. Biol. 75: 163-189.
26. Saha, B., S. Jyothi Prasanna, B. Chandrasekar, and D. Nandi. 2010. Gene modulation and immunoregulatory roles of interferon g. Cytokine 50: 1-14.
27. Sato, M., T. Taniguchi, and N. Tanaka. 2001. The interferon system and interferon regulatory factor transcription factors-studies from gene knockout mice. Cytokine Growth Factor Rev. 12: 133-142.
28. Sasaki, Y., S. Sano, M. Nakahara, S. Murata, K. Kometani, Y. Aiba, S. Sakamoto, Y. Watanabe, K. Tanaka, T. Kurosaki, and K. Iwai. 2013. Defective immune responses in mice lacking LUBAC-mediated linear ubiquitination in B cells. EMBO J. 32: 2463-2476.
29. Liang, Y. 2011. Chronic proliferative dermatitis in mice: NFkB activation autoinflammatory disease. Pathol. Res. Int. 2011: 936794.
30. Vucic, D., V. M. Dixit, and I. E. Wertz. 2011. Ubiquitylation in apoptosis: a posttranslational modification at the edge of life and death. Nat. Rev. Mol. Cell Biol. 12: 439-452.
31. Lee, E.-W., J.-H. Seo, M.-H. Jeong, S.-S. Lee, and J.-W. Song. 2012. The roles of FADD in extrinsic apoptosis and necroptosis. BMB Rep. 45: 496-508.
32. O'Donnell, M. A., D. Legarda-Addison, P. Skountzos, W. C. Yeh, and A. T. Ting. 2007. Ubiquitination of RIP1 regulates an NF-κB-independent cell-death switch in TNF signaling. Curr. Biol. 17: 418-424.
33. Brenner, C., L. Galluzzi, O. Kepp, and G. Kroemer. 2013. Decoding cell death signals in liver inflammation. J. Hepatol. 59: 583-594.
34. Makarov, R., P. Geserick, M. Feoktistova, and M. Leverkus. 2013. Cell death in the skin: how to study its quality and quantity? Methods Mol. Biol. 961: 201-218.
35. Abdulahad, D. A., J. Westra, P. C. Limburg, C. G. Kallenberg, and M. Bijl. 2010. HMGB1 in systemic lupus erythematosus: its role in cutaneous lesions development. Autoimmun. Rev. 9: 661-665.
36. HogenEsch, H., S. E. Torregrosa, D. Boggess, B. A. Sundberg, J. Carroll, and J. P. Sundberg. 2001. Increased expression of type 2 cytokines in chronic proliferative dermatitis (cpdm) mutant mice and resolution of inflammation following treatment with IL-12. Eur. J. Immunol. 31: 734-742.
37. Ohashi, R., R. Fukazawa, M. Watanabe, H. Tajima, N. Nagi-Miura, N. Ohno, S. Tsuchiya, Y. Fukuda, S. Ogawa, and Y. Itoh. 2013. Etanercept suppresses arteritis in a murine model of kawasaki disease: a comparative study involving different biological agents. Int. J. Vasc. Med. 2013: 543141.
38. Venegas-Pont, M., M. B. Manigrasso, S. C. Grifoni, B. B. LaMarca, C. Maric, L. C. Racusen, P. H. Glover, A. V. Jones, H. A. Drummond, and M. J. Ryan. 2010. Tumor necrosis factor-a antagonist etanercept decreases blood pressure and protects the kidney in a mouse model of systemic lupus erythematosus. Hypertension 56: 643-649.
39. Turner, D. A., P. Paszek, D. J. Woodcock, D. E. Nelson, C. A. Horton, Y. Wang, D. G. Spiller, D. A. Rand, M. R. White, and C. V. Harper. 2010. Physiological levels of TNFa stimulation induce stochastic dynamics of NF-κB responses in single living cells. J. Cell Sci. 123: 2834-2843.
40. Nakai, Y., S. Hamagaki, R. Takagi, A. Taniguchi, and F. Kurimoto. 1999. Plasma concentrations of tumor necrosis factor-a (TNF-α) and soluble TNF receptors in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 84: 1226-1228.
41. Wang, Z., A. Sokolovska, R. Seymour, J. P. Sundberg, and H. Hogenesch. 2012. SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells. PLoS ONE 7: e31809.
42. Rantala, J. K., J. Pouwels, T. Pellinen, S. Veltel, P. Laasola, E. Mattila, C. S. Potter, T. Duffy, J. P. Sundberg, O. Kallioniemi, et al. 2011. SHARPIN is an endogenous inhibitor of b1-integrin activation. Nat. Cell Biol. 13: 1315-1324.
43. Pasparakis, M., G. Courtois, M. Hafner, M. Schmidt-Supprian, A. Nenci, A. Toksoy, M. Krampert, M. Goebeler, R. Gillitzer, A. Israel, et al. 2002. TNFmediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature 417: 861-866.
44. Lind, M. H., B. Rozell, R. P. Wallin, M. van Hogerlinden, H. G. Ljunggren, R. Toftgård, and I. Sur. 2004. Tumor necrosis factor receptor 1-mediated signaling is required for skin cancer development induced by NF-κB inhibition. Proc. Natl. Acad. Sci. USA 101: 4972-4977.
45. Wullaert, A., M. C. Bonnet, and M. Pasparakis. 2011. NF-κB in the regulation of epithelial homeostasis and inflammation. Cell Res. 21: 146-158.
46. Lippens, S., E. Hoste, P. Vandenabeele, P. Agostinis, andW. Declercq. 2009. Cell death in the skin. Apoptosis 14: 549-569.
47. Schroder, K., M. J. Sweet, and D. A. Hume. 2006. Signal integration between IFNg and TLR signalling pathways in macrophages. Immunobiology 211: 511-524.
48. Ohmori, Y., and T. A. Hamilton. 2001. Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69: 598-604.
49. Jahnke, A., and J. P. Johnson. 1994. Synergistic activation of intercellular adhesion molecule 1 (ICAM-1) by TNF-α and IFN-γ is mediated by p65/p50 and p65/c-Rel and interferon-responsive factor Stat1 a (p91) that can be activated by both IFN-γ and IFN-α. FEBS Lett. 354: 220-226.
50. Boisson, B., E. Laplantine, C. Prando, S. Giliani, E. Israelsson, Z. Xu, A. Abhyankar, L. Israël, G. Trevejo-Nunez, D. Bogunovic, et al. 2012. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat. Immunol. 13: 1178-1186.
51. Callahan, J. A., G. E. Hammer, A. Agelides, B. H. Duong, S. Oshima, J. North, R. Advincula, N. Shifrin, H. A. Truong, J. Paw, et al. 2013. Cutting edge: ABIN-1 protects against psoriasis by restricting MyD88 signals in dendritic cells. J. Immunol. 191: 535-539.
52. Tejasvi, T., P. E. Stuart, V. Chandran, J. J. Voorhees, D. D. Gladman, P. Rahman, J. T. Elder, and R. P. Nair. 2012. TNFAIP3 gene polymorphisms are associated with response to TNF blockade in psoriasis. J. Invest. Dermatol. 132: 593-600.
53. Tokunaga, F., H. Nishimasu, R. Ishitani, E. Goto, T. Noguchi, K. Mio, K. Kamei, A. Ma, K. Iwai, and O. Nureki. 2012. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation. EMBO J. 31: 3856-3870.
54. Verhelst, K., I. Carpentier, M. Kreike, L.Meloni, L. Verstrepen, T. Kensche, I. Dikic, and R. Beyaert. 2012. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. EMBO J. 31: 3845-3855.
55. Oshima, S., E. E. Turer, J. A. Callahan, S. Chai, R. Advincula, J. Barrera, N. Shifrin, B. Lee, T. S. Benedict Yen, T. Woo, et al. 2009. ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development. Nature 457: 906-909.